We are live on ! Find out more
CC

Cannell & Co Portfolio holdings

AUM $3.15B
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
-10.13%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.51%
AUM
$3.08B
AUM Growth
-$454M
Cap. Flow
-$10.5M
Cap. Flow %
-0.34%
Top 10 Hldgs %
30.04%
Holding
290
New
20
Increased
70
Reduced
90
Closed
22

Top Sells

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$69.9M
2
WHR icon
Whirlpool
WHR
+$51.8M
3
HRB icon
H&R Block
HRB
+$37.9M
4
WPC icon
W.P. Carey
WPC
+$26.3M
5
CELG
Celgene Corp
CELG
+$25.3M

Sector Composition

Rank Sector Weight
1 Healthcare 21.57%
2 Industrials 19.91%
3 Technology 14.58%
4 Financials 10.22%
5 Energy 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAT icon
251
Mattel
MAT
$4.16B
$212K 0.01%
10,054
HGT
252
DELISTED
Hugoton Royalty Trust
HGT
$208K 0.01%
70,656
+1,100
+2% +$3.23K
AXP icon
253
American Express
AXP
$242B
$200K 0.01%
2,700
MCS icon
254
Marcus Corp
MCS
$708M
$195K 0.01%
10,100
CMO
255
DELISTED
Capstead Mortgage Corp.
CMO
$181K 0.01%
18,300
AVEO
256
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$154K 0.01%
12,750
LPSN icon
257
LivePerson
LPSN
$20.7M
$151K ﹤0.01%
1,333
ROKA
258
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$142K ﹤0.01%
7,320
OB
259
DELISTED
Onebeacon Insurance Group Ltd
OB
$140K ﹤0.01%
10,000
IMBI
260
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$131K ﹤0.01%
5,000
RIBT
261
DELISTED
RiceBran Technologies
RIBT
$95K ﹤0.01%
4,241
GNMK
262
DELISTED
GenMark Diagnostics, Inc
GNMK
$79K ﹤0.01%
10,000
PVCT
263
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
$52K ﹤0.01%
90,000
KOPN icon
264
Kopin
KOPN
$706M
$35K ﹤0.01%
11,000
TLOG
265
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$22K ﹤0.01%
11,713
ONCT
266
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$15K ﹤0.01%
14
BNBX
267
DELISTED
BNB PLUS CORP
BNBX
0
-$49K
CSTE icon
268
Caesarstone
CSTE
$79.2M
-4,600
Closed -$315K
DDD icon
269
3D Systems Corp
DDD
$439M
-180,580
Closed -$3.52M
FCNCA icon
270
First Citizens BancShares
FCNCA
$24.6B
-875
Closed -$230K
FWONA icon
271
Liberty Media Series A
FWONA
$23.5B
-9,810
Closed -$238K
GDXJ icon
272
VanEck Junior Gold Miners ETF
GDXJ
$6.63B
-9,125
Closed -$220K
GNRC icon
273
Generac Holdings
GNRC
$12.7B
-111,450
Closed -$4.43M
GOOG icon
274
Alphabet (Google) Class C
GOOG
$4.22T
-457,260
Closed -$12.1M
GWW icon
275
W.W. Grainger
GWW
$65.9B
-1,050
Closed -$248K

Similar funds

Cannell & Co's Q3 2015 Portfolio in Review

As of Q3 2015, Cannell & Co held 290 positions worth $3.08B, down 13% from $3.53B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Cannell & Co's Q3 2015 filing shows 20 new, 70 increased, 90 reduced and 22 closed positions. Its largest new stake was Vistance Networks Inc: 2,112,135 shares worth $63.4M. The largest sale was Paramount Global Class B, an estimated $69.9M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.

  • Cannell & Co's largest Q3 2015 buy was Vistance Networks Inc: 2,112,135 shares worth $63.4M.
  • Cannell & Co added most to WisdomTree in Q3 2015, an estimated $46M increase.
  • Cannell & Co's biggest Q3 2015 reduction was Paramount Global Class B, cutting an estimated $69.9M.
  • Cannell & Co fully exited Intercept Pharmaceuticals, Inc. in Q3 2015, selling an estimated $13.6M.
  • Cannell & Co's ten largest holdings make up 30% of its $3.08B portfolio in Q3 2015.
  • Cannell & Co opened 20 new positions and closed 22 in Q3 2015.
  • Cannell & Co's portfolio value fell 13% quarter-over-quarter to $3.08B.

Based on Cannell & Co's 13F filing for Q3 2015, filed 13 Nov 2015.